TheraRadar
← Back
Data updated: Jun 28, 2026

CSPC-NBP PHARM

Generics
Pharmaceuticals

CSPC-NBP PHARM is a generic drug manufacturer with 2 FDA-approved products.

2015
Since
2
Drugs
-
Trials
0
New Drugs (2yr)

CSPC-NBP PHARM's Key Drugs

CSPC-NBP PHARM's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

CSPC-NBP PHARM's Recent FDA Approvals

New NDA/BLA approvals for CSPC-NBP PHARM over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

CSPC-NBP PHARM's Therapeutic Areas

Disease areas where CSPC-NBP PHARM has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

CSPC-NBP PHARM Pipeline Snapshot

Active clinical trials for CSPC-NBP PHARM across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling